197 related articles for article (PubMed ID: 31141854)
1. Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod.
Kubicki SL; Park KE; Aung PP; Duvic M
J Drugs Dermatol; 2019 May; 18(5):460-462. PubMed ID: 31141854
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
Parajuli S; Gurung D; Paudel U; Pokhrel DB; Kempf W
Int J Dermatol; 2014 Dec; 53(12):1498-500. PubMed ID: 24738699
[No Abstract] [Full Text] [Related]
3. Primary cutaneous folliculotropic and lymphohistiocytic anaplastic large cell lymphoma.
Bittencourt AL; de Oliveira RF; Santos JB
J Cutan Med Surg; 2011; 15(3):172-6. PubMed ID: 21561587
[TBL] [Abstract][Full Text] [Related]
4. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
[No Abstract] [Full Text] [Related]
5. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
[TBL] [Abstract][Full Text] [Related]
7. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy task.
Diamantidis MD; Papadopoulos A; Kaiafa G; Ntaios G; Karayannopoulou G; Kostopoulos I; Girtovitis F; Saouli Z; Kontoninas Z; Raptis ID; Savopoulos C; Hatzitolios A
Int J Hematol; 2009 Sep; 90(2):226-229. PubMed ID: 19548068
[TBL] [Abstract][Full Text] [Related]
9. Brentuximab vedotin in CD30
Enos TH; Feigenbaum LS; Wickless HW
Int J Dermatol; 2017 Dec; 56(12):1400-1405. PubMed ID: 28762479
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas.
Martín JM; Ricart JM; Monteagudo C; Alcácer J; Pinazo I; Tomás L; Rausell N; Jordá E
Clin Exp Dermatol; 2007 Nov; 32(6):668-71. PubMed ID: 17953637
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
12. A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma.
Lyu WT; Song QB; Qiong W; Liu J; Yong R; Yi FT; Han DL
Medicine (Baltimore); 2021 May; 100(18):e25770. PubMed ID: 33950967
[TBL] [Abstract][Full Text] [Related]
13. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
14. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens.
Flores S; Luby NJ; Bowen GM
JAMA Dermatol; 2018 Apr; 154(4):482-484. PubMed ID: 29453870
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
[TBL] [Abstract][Full Text] [Related]
17. Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma.
Diamantidis MD; Myrou AD
ScientificWorldJournal; 2011 May; 11():1048-55. PubMed ID: 21552770
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
McNab PM; Jukic DM; Mills O; Browarsky I
Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
[TBL] [Abstract][Full Text] [Related]
19. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease.
Mahajan VK; Jindal R
Indian J Dermatol Venereol Leprol; 2016; 82(1):98-101. PubMed ID: 26728828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
